A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop ...
Its drug intermediates products include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine and 2-Chloro-5-Nitrobenzoic Acid.